Brief: Cytosorbents’ Pivotal Star-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
April 20 (Reuters) - Cytosorbents Corp CTSO.O :
* CYTOSORBENTS’ PIVOTAL STAR-T TRIAL REACHES SECOND KEY
MILESTONE
WITH 80 PATIENTS ENROLLED
Source text for Eikon: ID:nGNX8D37hM
Further company coverage: CTSO.O
((Reuters.Briefs@thomsonreuters.com;))